The Lymphoma Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
ASH 2025 | Lymphovision: an AI model for histology-based lymphoma classification and subtyping
Stephen Ansell, MD, PhD, Mayo Clinic, Rochester, MN, discusses Lymphovision, an artificial intelligence (AI)-generated large language model for histology-based lymphoma classification and subtyping. Prof. Ansell highlights that Lymphovision can rapidly identify lymphoma versus non-lymphoma, subtype lymphomas, and determine cell of origin. This interview took place at the 67th ASH Annual Meeting and Exposition, held in Orlando, FL.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
